Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSERA: Etanercept Tapering in RA
NCT00858780Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Primary completion
- Jun 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 6
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jan 2009; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00858780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858780.